Cargando…
Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials
A key issue with modern cancer treatments is the emergence of resistance to conventional chemotherapy and molecularly targeted medicines. Cancer nanotherapeutics were created in order to overcome the inherent limitations of traditional chemotherapeutics. Over the last few decades, cancer nanotherape...
Autor principal: | Bukhari, Syed Nasir Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028322/ https://www.ncbi.nlm.nih.gov/pubmed/35456698 http://dx.doi.org/10.3390/pharmaceutics14040866 |
Ejemplares similares
-
Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer
por: Saha, Tanmoy, et al.
Publicado: (2021) -
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
por: Dissanayake, Ranga, et al.
Publicado: (2023) -
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021) -
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
por: Shaurova, Tatiana, et al.
Publicado: (2023) -
Smart Nanotherapeutics and Lung Cancer
por: Doroudian, Mohammad, et al.
Publicado: (2021)